一步保守性手术与子宫切除术治疗胎盘植入谱系的可行性随机对照试验
该前瞻性注册的多中心随机对照试验将60例产前高度怀疑胎盘植入谱系的孕妇随机分配至子宫切除术组(n=31)或一步保守性手术组(n=29),20个月内64例合格患者中60例(93.7%)完成随机化。意向性分析显示一步保守性手术的临床结局与子宫切除术相当,在 topographic classification 1型亚组中一步手术结局更优。结论为比较两种手术技术的随机对照试验可行,一步保守性修复在大多数病例中是可替代子宫切除术的有效选择,但需术中手术分期确定。
要点
- 一步保守性手术与子宫切除术的临床结局在意向性分析中相当。
- topographic classification 1型亚组中一步手术手术时间更短、输血率更低。
- 一步保守性修复可作为大多数病例的子宫切除术替代方案,但需术中分期确定。
核心结论
- 比较两种治疗胎盘植入谱系手术技术的随机对照试验是可行的。
- 一步保守性修复在大多数病例中是可替代子宫切除术的有效选择,但仅在术中手术分期后才能确定。
研究设计与样本
- 前瞻性注册的多中心随机对照试验,将60例产前高度怀疑胎盘植入谱系的孕妇随机分配至子宫切除术组(n=31)或一步保守性手术组(n=29)。
- 20个月期间,64例合格患者中60例(93.7%)接受了随机化。
主要发现
- 意向性分析显示一步保守性手术的临床结局与子宫切除术相当:术中失血量中位数1740 mL(四分位距1010-2410)vs 1500 mL(四分位距1122-2753),比值比1(1-1),P=.942。
- 手术时间中位数135分钟(四分位距111-180)vs 155分钟(四分位距120-185),比值比0.99(0.98-1),P=.151。
- 输血率58.6% vs 61.3%,比值比0.96(0.83-1.76),P=.768;不良事件率17.2% vs 9.7%,比值比1.77(0.43-10.19),P=.398。
- 在 topographic classification 1型亚组中,分配至一步手术的所有参与者均获得成功结局,优于子宫切除术:手术时间中位数125分钟(四分位距98-128)vs 180分钟(129-226),P=.002;输血率46.2% vs 82.4%;红细胞输注单位数中位数1单位(四分位距1-1.8)vs 3单位(四分位距2-4),P=.007。
临床怎么用
- 作者认为一步保守性修复在大多数病例中是可替代子宫切除术的有效选择,但仅在术中手术分期后才能确定。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Placenta accreta spectrum is a serious condition associated with significant maternal morbidity and even mortality. The recommended treatment is hysterectomy. An alternative is 1-step conservative surgery, which involves the en bloc resection of the myometrium affected by placenta accreta spectrum along with the placenta, followed by uterine reconstruction. Currently, there are no studies comparing the 2 techniques in the setting of a randomized controlled trial. OBJECTIVE: We performed a prospectively registered multicenter randomized controlled trial comparing hysterectomy with 1-step conservative surgery. The aim was to collect feasibility and clinical outcomes of the 2 techniques in women assigned to hysterectomy or 1-step conservative surgery. In addition to assessing participants' willingness to be randomized, we also collected data on intraoperative blood loss, transfusion requirement, serious adverse event, and other clinical outcomes. STUDY DESIGN: Sixty women with strong antenatal suspicion of placenta accreta spectrum were assigned randomly to either hysterectomy (n=31) or 1-step conservative surgery (n=29). RESULTS: During a 20-month period, 60 of the 64 eligible patients (93.7%) underwent randomization. Intention-to-treat analysis showed that the clinical outcomes for 1-step conservative surgery were comparable to those of hysterectomy (median intraoperative blood loss, 1740 mL [interquartile range, 1010-2410] vs 1500 mL [interquartile range, 1122-2753]; odds ratio, 1 [1-1]; P=.942; median duration of surgery, 135 minutes [interquartile range, 111-180] vs 155 minutes [interquartile range, 120-185]; odds ratio, 0.99 [0.98-1]; P=.151; transfusion rate, 58.6% vs 61.3%; odds ratio, 0.96 [0.83-1.76]; P=.768; and adverse event rate, 17.2% vs 9.7%; odds ratio, 1.77 [0.43-10.19]; P=.398; respectively). In the subgroup of women with type 1 class on topographic classification, all participants allocated to 1-step surgery had successful outcomes, which were superior to those of hysterectomy. This was evidenced by the shorter surgery duration (median, 125 [interquartile range, 98-128] vs 180 [129-226] minutes; P=.002), lower transfusion rates (46.2% vs 82.4%), and fewer units of red blood cells transfused (median, 1 [interquartile range, 1-1.8] vs 3 [interquartile range, 2-4] units; P=.007). CONCLUSION: A randomized controlled trial comparing 2 surgical techniques for the treatment of placenta accreta spectrum is feasible. One-step conservative repair is a valid alternative to hysterectomy in the large majority of cases, but this can only be ascertained following intraoperative surgical staging. El resumen está disponible en Español al final del artículo.
引用
- Nieto-Calvache ÁJ, Aryananda RA, Palacios-Jaraquemada JM, et al. One-step conservative surgery vs hysterectomy for placenta accreta spectrum: a feasibility randomized controlled trial. Am J Obstet Gynecol MFM. 2024. PMID: 38458362. doi:10.1016/j.ajogmf.2024.101333
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。